Skip to main content
. 2016 Sep;138(3):e20160731. doi: 10.1542/peds.2016-0731

TABLE 2.

The Association Between β Blockers (Overall) and the Risks of Neonatal Hypoglycemia and Neonatal Bradycardia

β Blocker Exposed β Blocker Nonexposed OR (95% CI)
Outcomes Total Outcomes Total
Neonatal hypogylcemia
 Unadjusted 460 10 585 27 228 2 281 531 3.76 (3.42–4.13)
 PS-matched 459 10 561 834 31 683 1.68 (1.50–1.89)
Neonatal bradycardia
 Unadjusted 165 10 585 11 659 2 281 531 3.08 (2.64–3.6)
 PS-matched 165 10 561 385 31 683 1.29 (1.07–1.55)